{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:41:35Z","timestamp":1789238495027,"version":"build-2803163510"},"reference-count":50,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rigel Pharmaceuticals Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2025,8,24]]},"DOI":"10.1080\/10428194.2025.2514894","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:19:17Z","timestamp":1749791957000},"page":"1821-1832","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of olutasidenib versus ivosidenib in patients with mutated isocitrate dehydrogenase 1 acute myeloid leukemia who are relapsed or refractory to venetoclax: the 2102-HEM-101 trial versus a US electronic health record-based external control arm"],"prefix":"10.1080","volume":"66","author":[{"given":"Catherine E.","family":"Lai","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3958-6224","authenticated-orcid":false,"given":"Thomas P.","family":"Leahy","sequence":"additional","affiliation":[{"name":"Putnam Associates","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Turner","sequence":"additional","affiliation":[{"name":"Putnam Associates","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Thomassen","sequence":"additional","affiliation":[{"name":"Rigel Pharmaceuticals, Inc","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[{"name":"Rigel Pharmaceuticals, Inc","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Rigel Pharmaceuticals, Inc","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-1071","authenticated-orcid":false,"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[{"name":"Georgia Cancer Center, Augusta University","place":["Augusta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.018"},{"key":"e_1_3_4_3_1","unstructured":"National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Acute Myeloid Leukemia. Version 3.2024. Retrieved from https:\/\/www.nccn.org"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27231"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000562500.21650.32"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24072"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092506"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0083"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1231677"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10860"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152\u20132650(24)00516-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01423"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.38"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1618605114"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009411"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009854"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106942"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00915-6"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.e13572"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024895"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011666"},{"key":"e_1_3_4_23_1","unstructured":"National Institute for Health and Care Excellence. (2022). NICE real-world evidence framework. https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/real-world-evidence-framework"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.01.015"},{"key":"e_1_3_4_25_1","unstructured":"U.S. Food and Drug Administration. (2022). Submitting documents using real-world data and real-world evidence to FDA for drug and biological products. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/submitting-documents-using-real-world-data-and-real-world-evidence-fda-drug-and-biological-product"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4182"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S242097"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2913"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2914"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7447"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.015"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.312"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24781"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1223858"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01141-x"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.036"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106946"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/pan\/mpr025"},{"key":"e_1_3_4_40_1","unstructured":"Greifer N. WeightIt: weighting for covariate balance in observational studies. R package version 1.3; 2024.2. Available from: https:\/\/ngreifer.github.io\/WeightIt\/"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.01.010"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102819"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3785"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00022"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201903-241OC"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3587"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2752"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181875e61"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01657-z"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207476"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208771"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2514894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:06:39Z","timestamp":1759273599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2514894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8,24]]}},"alternative-id":["10.1080\/10428194.2025.2514894"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2514894","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}